Rapid Reversal of Dabigatran Anticoagulation With Idarucizumab

Idarucizumab rapidly and consistently reverses the anticoagulant effect of oral agent dabigatran, aiding patients with bleeds and allowing emergency invasive procedures, the RE-VERSE AD study shows.